P116 Histone Deacetylase 1: A Novel Therapeutic Target for Patients With Rheumatoid Arthritis

doi 10.1136/annrheumdis-2018-ewrr2018.131
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

P062 Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target in Rheumatoid Arthritis

2019English

Progranulin: A Promising Therapeutic Target for Rheumatoid Arthritis

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2011English

Histone Deacetylase 8 as a Novel Therapeutic Target in Oral Squamous Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

KCa1.1 (BK) Channels on Fibroblast-Like Synoviocytes: A Novel Therapeutic Target for Rheumatoid Arthritis

Biophysical Journal
Biophysics
2015English

Etanercept: Therapeutic Use in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1999English

Blocking Histone Deacetylase Activity as a Novel Target for Epithelial Barrier Defects in Allergic Rhinitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Holocarboxylase Synthetase Interacts Physically With Nuclear Receptor Co-Repressor, Histone Deacetylase 1 and a Novel Splicing Variant of Histone Deacetylase 1 to Repress Repeats

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2014English

Erratum: TNF Defined as a Therapeutic Target for Rheumatoid Arthritis and Other Autoimmune Diseases

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2003English

Semaphorin 7A as a Potential Immune Regulator and Promising Therapeutic Target in Rheumatoid Arthritis

Arthritis Research & Therapy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy